Skip to main content
IXHL logo

Incannex Healthcare Inc.

IXHLNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$2.82Today:- (-)1Y +726.64%

As of Oct 16, 2026 close

Market cap
$33.58M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.30$14.07
Volume (live)
-
Avg. volume (3M)
82.08K

Incannex Healthcare (IXHL) Cash Flow Statement

In fiscal 2026 (fiscal year ended Jun 30, 2026), Incannex Healthcare used AUD 12.87M of cash in operating activities and spent AUD 10.00K on capital expenditures. That left free cash flow of −AUD 12.88M.

Incannex Healthcare Cash Flow Statement Analysis

Values in millions AUD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Incannex Healthcare Inc. (IXHL) - Annual data in millions AUD
BreakdownFY 2026FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Sep 2024Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Operating Activities
Net Income-19.30-46.89-18.46-18.46-48.81-14.90-11.39-4.68-2.73-2.96-20.38
Depreciation & Amortization0.240.250.100.100.090.000.000.000.000.0618.05
Stock Based Compensation7.562.618.938.932.151.470.450.560.050.070.15
Change in Working Capital0.006.78-9.47-6.4535.830.120.00-0.370.060.04-0.21
Change in Accounts Receivable0.005.580.00-0.00-0.090.22-0.31-0.040.04-0.05
Change in Inventory0.000.000.00-0.000.000.14-0.030.070.00-0.17
Change in Accounts Payable0.001.390.003.021.100.000.000.000.000.000.00
Change in Other Working Capital0.00-0.19-9.47-9.470.000.212.91-0.030.030.000.01
Other Operating Activities-1.3624.743.050.030.000.462.910.600.41-0.20-0.30
Net Cash from Operating Activities-12.87-12.51-15.85-15.85-10.75-12.85-5.19-3.89-2.21-3.00-2.70
Investing Activities
Capital Expenditures-0.01-0.01-0.28-0.28-0.320.000.000.00-0.02-0.05-0.05
Acquisitions0.000.000.00-0.000.000.030.010.000.003.07
Other Investing Activities-0.080.000.00-0.000.000.000.000.000.000.00
Net Cash from Investing Activities-0.09-0.01-0.28-0.28-0.320.000.020.01-0.02-0.053.02
Financing Activities
Debt Repayment0.00-1.310.00--0.040.000.00-0.06-0.14-0.200.17
Common Stock Issued0.0047.470.00-8.1843.419.327.232.242.970.00
Other Financing Activities65.90-24.770.00-0.05-2.230.000.210.00-0.010.01
Net Cash from Financing Activities65.9021.400.00-8.1841.189.327.372.102.760.18
Summary
Effect of Forex Changes on Cash-0.270.31-0.14-0.14-0.820.000.330.00-0.040.010.00
Net Change in Cash52.679.18-16.26-16.26-2.8928.374.153.49-0.18-0.280.50
Cash at Beginning of Period15.045.8622.1222.1225.839.122.710.090.270.510.00
Cash at End of Period67.7115.045.865.8622.1237.636.853.590.090.230.51
Free Cash Flow-12.88-12.52-16.12-16.12-11.07-12.85-5.19-3.89-2.19-3.05-2.75

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Incannex Healthcare Cash Flow

What is Incannex Healthcare's free cash flow?

Incannex Healthcare had negative free cash flow of AUD 12.88M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −AUD 12.87M minus AUD 10.00K of capital expenditures.

How much does Incannex Healthcare spend on capital expenditures?

Incannex Healthcare spent AUD 10.00K on capital expenditures in fiscal 2026, compared with AUD 8.00K a year earlier.

Does Incannex Healthcare pay dividends or buy back shares?

Incannex Healthcare's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition